All In Biotech

Drug Trial Radar · NCT05811351

A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Last checked: Nov 20, 2026Latest source record: Mar 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 305 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

305

Actual

Start

Mar 6, 2023

Primary completion

Feb 23, 2026

Study completion Feb 23, 2026

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Apr 13, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate change in geographic atrophy (GA) lesion growth of eyes treated with JNJ-81201887 compared to sham control.

Conditions

  • Geographic Atrophy

Interventions

  • JNJ-81201887Drug

    JNJ-81201887 will be administered as intravitreal injection.

  • PrednisoneDrug

    Prednisone will be administered as oral capsule.

  • PlaceboOther

    Prednisone matching placebo will be administered as oral capsule.

  • TriamcinoloneDrug

    Triamcinolone (corticosteroid injection) periocular injection will be administered as per local practice.

  • Sham ProcedureOther

    Sham injections matching to single JNJ-81201887 injection and matching to corticosteroid (triamcinolone) periocular injection will be administered.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Global: Change From Baseline in Square Root of Geographic Atrophy (GA) Lesion Area in the Study Eye at Month 18Time frame: Baseline and Month 18
  2. United States (U.S.) Specific: Rate of Change in Untransformed GA Lesion Area in the Study EyeTime frame: Baseline to Month 18

Locations

162 sites in 17 countries. Site status is shown where the registry gives one.

  • Retinal Research Institute

    Phoenix, Arizona

  • Retina Associates Southwest PC

    Tucson, Arizona

  • Retina Consultants of Orange County

    Fullerton, California

  • Retina Associates Of Southern California

    Huntington Beach, California

  • Shiley Eye Institute Jacobs Retina Center

    La Jolla, California

  • Jules Stein Eye Institute UCLA

    Los Angeles, California

  • The Retina Partners

    Los Angeles, California

  • California Retina Consultants

    Oxnard, California

  • Stanford Health Care

    Palo Alto, California

  • California Eye Medical Specialists

    Pasadena, California

  • Retina Consultants San Diego

    Poway, California

  • Retina Consultants of Southern California

    Redlands, California

  • Bay Area Retina Associates

    Walnut Creek, California

  • Colorado Retina - Lakewood Clinic

    Lakewood, Colorado

  • Retina Group of Florida

    Fort Lauderdale, Florida

  • National Opthalmic Research Institute

    Fort Myers, Florida

  • VitreoRetinal Associates, PA

    Gainesville, Florida

  • MedEye Associates

    Miami, Florida

  • Retina Specialty Institute

    Pensacola, Florida

  • Fort Lauderdale Eye Institute

    Plantation, Florida

  • Retina Vitreous Associates of Florida

    St. Petersburg, Florida

  • East Florida Eye Institute

    Stuart, Florida

  • Georgia Retina

    Marietta, Georgia

  • Marietta Eye Clinic

    Marietta, Georgia

  • University Of Illinois

    Chicago, Illinois

  • Retina Associates

    Elmhurst, Illinois

  • University Retina

    Lemont, Illinois

  • Midwest Eye Institute

    Carmel, Indiana

  • Maine Eye Center

    Portland, Maine

  • Retina Specialists

    Baltimore, Maryland

  • The Retina Care Center

    Baltimore, Maryland

  • The Retina Group of Washington

    Chevy Chase, Maryland

  • Cumberland Valley Retina Consultants

    Hagerstown, Maryland

  • Ophthalmic Consultants of Boston

    Boston, Massachusetts

  • Vitreo Retinal Associates-Worcester

    Worcester, Massachusetts

  • Foundation for Vision Research

    Grand Rapids, Michigan

  • Associated Retinal Consultants P.C.

    Royal Oak, Michigan

  • Retina Consultants of Minnesota

    Saint Louis Park, Minnesota

  • The Retina Institute

    St Louis, Missouri

  • Sierra Eye Associates

    Reno, Nevada

Showing 40 of 162 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.